Total lymphocyte count as a surrogate marker for CD4+ T cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi

East African Medical Journal

Volumn 84, Issue 10, 2007, Pages 466-472

  Gitura, B ^a   Joshi, M D ^a,b   Lule, G N ^a   Anzala, O ^b  

^a Department of Clinical Medicine and Therapeutics ^*

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER;

ARTICLE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DECISION SUPPORT SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LYMPHOCYTE; LYMPHOCYTE COUNT; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DECISION SUPPORT SYSTEMS, CLINICAL; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; KENYA; LYMPHOCYTE COUNT; LYMPHOCYTES; TREATMENT OUTCOME;

EID: 38349118016     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dayton J.M. and Merson M.H., Global dimensions of the AIDS epidemic: Implications for prevention and care. Infect. Dis. Clin. North Amer. 2000; 14: 4-9.
2. Palele F.J., Knoll M. and Chmiel J.S. Survival benefit of initiating antiretroviral therapy in HIV infected persons in different CD4 cell strata. Ann. Intern. Med. 2003; 138: 620-626.
3. National AIDS and STI Control Programme, Ministry of Health, Kenya. AIDS in Kenya, 7th Edition. Nairobi: NASCOP. 2005.
4. Cohen J., Kimaiyo S. and Winstone N. Addressing the educational void during the antiretroviral therapy rollout. AIDS. 2004; 18: 2105-2106.
5. Cohen J. The high cost of poverty. Science. 2002; 296: 2324.
6. World Health Organization; Scaling up antiretroviral therapy in resource limited settings: guidelines for a public health approach. Executive summary Geneva: WHO; 2002.
7. Blatt S.P., Lucey C.R., Butzin C.A., et al. Total lymphocyte counts as a predictor of absolute CD4 count and CD4 percentage in HIV infected persons. JAMA. 1993; 269: 622-626.
8. Beck E.J., Kupeck E.J., Compels M.M. and Pinching A.J. Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect. Int. J. STD AIDS. 1996; 7: 422-428.
9. Kamya M.R., Semitala F.G., Quinn T.C., et al. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala Uganda. Afr. Health Sci. 2004; 2: 941.
10. Badri M. and Wood R. Usefulness of total lymphocyte counts in monitoring highly active antiretroviral therapy in resource-limited settings. AIDS. 2003; 17: 541-545.
11. Anish P., Hogan J.W., Brad Snyder., et al. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART. Implications for monitoring in resource limited settings. J. AIDS. 2004; 36: 567-575.
12. Mwamburi M.D., Mayurika G., Sherwood L., et al. Predicting CD4 count using total lymphocyte count: A sustainable tool for clinical decisions during HAART use. Amer. J. Trop. Med. Hyg. 2005; 73: 58-62.
13. van der Ryst., Eina., Kotze M., Joubert G., et al. Correlation among total lymphocyte count. Absolute CD4 count and CD4 percentage in a Group of HIV-1 infected South African patients. J. AIDS Human Retrov. 1998; 19: 238-244.
14. Akanmu A.S., Akinsete I., Eshofonie A.O., et al. Absolute lymphocyte count as surrogate for CD4 cell count in monitoring response to antiretroviral therapy. Niger. Post Grad. Med. J. 2001; 8: 105-111.
15. The WHO International Collaborating Group for the study of the WHO staging System: AIDS. 1993; 7: 711-718.
16. Hermann B., William C. and Kereng V. Low CD4 T-lymphocyte values in HIV negative adults in Botswana. Clin. Diag. Lab. Immul. 2004; 11: 930-935.
17. Kassa E., Tobias F., Ermias H., et al. Evaluation of the WHO staging system for HIV infection and disease in Ethiopia. AIDS. 1999; 13: 381-389.
18. Kalinkovich A., Weisman Z., Burstein R. and Bentwich Z. Standard values of T-lymphocyte subsets in Africa. J. AIDS Hum. Retrovirol. 1998; 17: 183-185.
19. Dacie and Lewis. Practical Hematology 9th edition 2001. p 15-18. Edited by S.M. Lewis, B.J. Bain and J. Bater.
20. Liotta G., et al. Is total lymphocyte count a reliable predictor of the CD4 lymphocyte cell count in resource limited settings? AIDS. 2004; 18: 1082.